Results: 1-25 | 26-34
Results: 1-25/34

Authors: Pittet, MJ Speiser, DE Valmori, D Rimoldi, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247

Authors: Romero, P Dutoit, V Rubio-Godoy, V Lienard, D Speiser, D Guillaume, P Servis, K Rimoldi, D Cerottini, JC Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S

Authors: Pittet, MJ Speiser, DE Lienard, D Valmori, D Guillaume, P Dutoit, V Rimoldi, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S

Authors: Rubio-Godoy, V Dutoit, V Rimoldi, D Lienard, D Lejeune, F Speiser, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307

Authors: Speiser, DE Colonna, M Ayyoub, M Cella, M Pittet, MJ Batard, P Valmori, D Guillaume, P Lienard, D Cerottini, JC Romero, P
Citation: De. Speiser et al., The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells, J IMMUNOL, 167(11), 2001, pp. 6165-6170

Authors: Navazo, MDP Valmori, D Ruegg, C
Citation: Mdp. Navazo et al., The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferationand cytokine production, J IMMUNOL, 167(11), 2001, pp. 6431-6440

Authors: Blanchet, JS Valmori, D Dufau, I Ayyoub, M Nguyen, C Guillaume, P Monsarrat, B Cerottini, JC Romero, P Gairin, JE
Citation: Js. Blanchet et al., A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: Implication for molecular anti-melanoma immunotherapy, J IMMUNOL, 167(10), 2001, pp. 5852-5861

Authors: Pittet, MJ Zippelius, A Speiser, DE Assenmacher, M Guillaume, P Valmori, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases, J IMMUNOL, 166(12), 2001, pp. 7634-7640

Authors: Rimoldi, D Muehlethaler, K Salvi, S Valmori, D Romero, P Cerottini, JC Levy, F
Citation: D. Rimoldi et al., Subcellular localization of the melanoma-associated protein Melan-A(MART-1) influences the processing of its HLA-A2-restricted epitope, J BIOL CHEM, 276(46), 2001, pp. 43189-43196

Authors: Ayyoub, M Migliaccio, M Guillaume, P Lienard, D Cerottini, JC Romero, P Levy, F Speiser, DE Valmori, D
Citation: M. Ayyoub et al., Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing., EUR J IMMUN, 31(9), 2001, pp. 2642-2651

Authors: Speiser, DE Migliaccio, M Pittet, MJ Valmori, D Lienard, D Lejeune, F Reichenbach, P Guillaume, P Luscher, I Cerottini, JC Romero, P
Citation: De. Speiser et al., Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, EUR J IMMUN, 31(2), 2001, pp. 459-466

Authors: Dietrich, PY Walker, PR Quiquerez, AL Perrin, G Dutoit, V Lienard, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054

Authors: Valmori, D Dutoit, V Rubio-Godoy, V Chambaz, C Lienard, D Guillaume, P Romero, P Cerottini, JC Rimoldi, D
Citation: D. Valmori et al., Frequent cytolytic T-cell responses to peptide IMAGE-A10(254-262) in melanoma, CANCER RES, 61(2), 2001, pp. 509-512

Authors: Dutoit, V Rubio-Godoy, V Dietrich, PY Quiqueres, AL Schnuriger, V Rimoldi, D Lienard, D Speiser, D Guillaume, P Batard, P Cerottini, JC Romero, P Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856

Authors: Pinilla, C Rubio-Godoy, V Dutoit, V Guillaume, P Simon, R Zhao, YD Houghten, RA Cerottini, JC Romero, P Valmori, D
Citation: C. Pinilla et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, CANCER RES, 61(13), 2001, pp. 5153-5160

Authors: Gonzalez, JM Peter, K Esposito, F Nebie, I Tiercy, JM Bonelo, A Arevalo-Herrera, M Valmori, D Romero, P Herrera, S Corradin, G Lopez, JA
Citation: Jm. Gonzalez et al., HLA-A0201 restricted CD8+T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT, PARASITE IM, 22(10), 2000, pp. 501-514

Authors: Migliaccio, M Amacker, M Just, T Reichenbach, P Valmori, D Cerottini, JC Romero, P Nabholz, M
Citation: M. Migliaccio et al., Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8(+) lymphocyte immortalization, J IMMUNOL, 165(9), 2000, pp. 4978-4984

Authors: Rimoldi, D Rubio-Godoy, V Dutoit, V Lienard, D Salvi, S Guillaume, P Speiser, D Stockert, E Spagnoli, G Servis, C Cerottini, JC Lejeune, F Romero, P Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261

Authors: Valmori, D Dutoit, V Lienard, D Lejeune, F Speiser, D Rimoldi, D Cerundolo, V Dietrich, PY Cerottini, JC Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538

Authors: Pittet, MJ Speiser, DE Valmori, D Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Cutting edge: Cytolytic effector function in human circulating CD8(+) T cells closely correlates with CD56 surface expression, J IMMUNOL, 164(3), 2000, pp. 1148-1152

Authors: Valmori, D Levy, F Miconnet, I Zajac, P Spagnoli, GC Rimoldi, D Lienard, D Cerundolo, V Cerottini, JC Romero, P
Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131

Authors: Bonelo, A Valmori, D Triponez, F Tiercy, JM Mentha, G Oberholzer, J Champagne, P Romero, JF Esposito, F Nebie, I Barbey, C Romero, P Herrera, S Corradin, G Lopez, JA
Citation: A. Bonelo et al., Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentation by liver cells, EUR J IMMUN, 30(11), 2000, pp. 3079-3088

Authors: Valmori, D Dutoit, V Lienard, D Rimoldi, D Pittet, MJ Champagne, P Ellefsen, K Sahin, U Speiser, D Lejeune, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506

Authors: Valmori, D Fonteneau, JF Valitutti, S Gervois, N Dunbar, R Lienard, D Rimoldi, D Cerundolo, V Jotereau, F Cerottini, JC Speiser, DE Romero, P
Citation: D. Valmori et al., Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues, INT IMMUNOL, 11(12), 1999, pp. 1971-1979

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093
Risultati: 1-25 | 26-34